Ledger.Open graph →

SEC Form D · filed August 22, 2017

Alzamend Neuro, Inc

Offering

$4.0M

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SALT LAKE CITY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Matthew Ogle · Eden Prairie, MNExec · Director John M. Pons · PHOENIX, AZExec · Director D. K. Mcallaster, Jr · PHOENIX, AZDirector Juan Sabater · Seattle, WAExec · Director Joseph Hanauer · Seattle, WAExec · Director Matthew Ehrlichman · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗